<?xml version="1.0" encoding="UTF-8"?>
<p>On the other hand, another drug marketed to treat skin lesions due to HSV-2 infection is Viroxyn
 <sup>®</sup> (Quadex Pharmaceuticals), which consists of benzalkonium chloride, a Category III antiseptic, that is also used for various applications, mainly as a biocidal preservative. This compound would act as a virucidal agent over herpes simplex viruses (
 <xref rid="B13" ref-type="bibr">Bélec et al., 2000</xref>). Although Viroxyn has been sold for more than 16 years, there are only limited studies that have evaluated its effectiveness, some proposing that it is more effective than Abreva
 <sup>®</sup> (
 <xref rid="B126" ref-type="bibr">McCarthy et al., 2012</xref>). However, in 2016 the FDA announced a ban on the sale of numerous bactericidal ingredients, leaving benzalkonium chloride in a “stand-by” status until obtaining clinical results that prove its safety in humans, so it may eventually be recalled (“Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use.” 2016-09-06. Retrieved October 05, 2016) (
 <xref rid="B201" ref-type="bibr">Wolf, 2017</xref>).
</p>
